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Background: Acute cholecystitis is a common diagnosis. However, the heterogeneity of presentation makes it
difficult to standardize management. Although surgery is the mainstay of treatment, critically ill patients have been
managed via percutaneous cholecystostomy. However, the role of percutaneous cholecystostomy in the management
of such patients has not been clearly established. This systematic review will compare the outcomes of critically ill
patients with acute cholecystitis managed with percutaneous cholecystostomy to those of similar patients managed
with cholecystectomy.
Methods/design: Systematic searches will be conducted across relevant health databases including the Cochrane
Library, Cumulative Index of Nursing and Allied Health Literature (CINAHL), MEDLINE, Embase, and Scopus using the
following keywords: (acute cholecystitis OR severe cholecystitis OR cholecystitis) AND (cholecystectomy OR
laparoscopic cholecystectomy OR open cholecystectomy) AND (Cholecystostomy OR percutaneous cholecystectomy
OR gallbladder drain OR gallbladder tube OR transhepatic gallbladder drain OR transhepatic gallbladder tube OR
cholecystostomy tube). The reference lists of eligible articles will be hand searched. Articles from 2000–2014 will be
identified using the key terms “acute cholecystitis, cholecystectomy, and percutaneous cholecystostomy”. Studies
including both interventions will be included. Relevant data will be extracted from eligible studies using a specially
designed data extraction sheet. The Newcastle-Ottawa scale will be used to assess the quality of non-randomized
studies. Central tendencies will be reported in terms of means and standard deviations where necessary, and risk ratios
will be calculated where possible. All calculations will be performed with a 95 % confidence interval. Furthermore, the
Fisher’s exact test will be used for the calculation of significance, which will be set at p < 0.05. Pooled estimates will be
presented after consideration of both clinical and methodological heterogeneity of included studies. Both interventions
would be compared with regard to in-hospital mortality, 30-day mortality, procedure-dependent complications,
re-intervention, length of intensive care unit (ICU) stay, length of hospital stay, re-admission, and cost of treatment.
The review will be reported using the Preferred Reporting Items for Systematic Reviews and Meta-Analysis
(PRISMA) statement.
Discussion: This systematic review aims at identifying and evaluating the clinical value of percutaneous
cholecystostomy in the management of critically ill patients with acute cholecystitis.
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Acute cholecystitis (AC) describes an acute gallbladder
inflammation and is a common cause for a visit to the
emergency department [1]. Although gallbladder stones
are present in the vast majority of cases (calculous
cholecystitis), gallbladder inflammation is possible in the
absence of stones (acalculous cholecystitis). Patients usu-
ally present with pain to the right upper quadrant with
fever and chills. AC is easily diagnosed using the param-
eters outlined in the Tokyo (TG13) guidelines. These
guidelines employ information from history, physical
examination, blood chemistry, and ultrasound sonog-
raphy to diagnose AC. Besides providing diagnostic cri-
teria, the TG13 guidelines enable a classification of AC
in three severity grades; mild cholecystitis (grade I),
moderate cholecystitis (grade II), and severe cholecystitis
with organ failure (grade III) [2, 3].
Cholecystectomy, that is the surgical removal of the
gallbladder, is generally accepted as the standard treat-
ment for “fit for surgery” patients with AC [4–8]. Now-
adays, the minimal invasive laparoscopic technique is
the standard procedure for the management of benign
gallbladder pathologies including AC. However, the man-
agement of critically ill patients with AC remains contro-
versial. Although surgery has been employed in such
patients, increased risk of perioperative morbidity and
mortality due to reduced physiologic reserve is of concern.
Thus, percutaneous cholecystostomy (PC), i.e., draining
the inflamed gallbladder under local anesthesia, has been
proposed and employed in the management of such pa-
tients, especially after failure of medical therapy [9–13].
Currently, many research groups have published their
experience with PC either as a bridge to surgery or as a
definitive intervention in critically ill patients with AC
[11, 14, 15]. Although the results presented by some of
these series appear acceptable, the small size of the study
population, the retrospective study design, and possible
selection bias limit their clinical value. More so, the clin-
ical value of PC in the management of critically ill pa-
tients with cholecystitis could not be established in a
systematic review by Winbladh et al. [16] in 2007. Simi-
larly, a Cochrane review by Gurusamy et al. [17] in 2013
failed to identify the clinical significance of PC in the
management of AC. This review included just 156 patients
from two randomized studies and was inconclusive with
regard to the clinical benefit of PC in the management of
critically ill patients with AC.
In a recently published 10-year retrospective analysis,
Abi-Haidar et al. [18] reported longer intensive care unit
stay and hospital stay in patients managed with PC. In
this series, PC was associated with higher morbidity and
re-admission rates compared to CC. A similar trend was
reported in a large retrospective series by Anderson and
colleagues [19]. The rate of mortality for PC in theirseries of 43.341 patients was 61.7 %. The authors con-
cluded, “PC may not benefit the sickest patients in
whom cholecystectomy may never be considered”.
The heterogeneity of clinical presentation and comor-
bidities of patients with AC makes it extremely difficult to
standardize management. Therefore, the clinical decision-
making may not always be clear. This is especially true for
elderly and critically ill patients with reduced physiologic
reserve. However, modern surgical techniques as well
as advances in anesthesiology and intensive care medi-
cine could permit primary gallbladder surgery in critic-
ally ill patients.
This systematic review will compare the outcomes of
critically ill patients managed with PC to those of similar
patients managed with CC with the primary aim of es-
tablishing the clinical role of PC in the management of
critically ill patients with AC.Objectives
This review will provide an overview of published data
on PC and CC in the management of critically ill pa-
tients with AC. The clinical benefit of PC in the manage-
ment of this subgroup of patients will be investigated by
comparing the outcomes of both interventions.Methods/design
Study type
We will consider all studies comparing CC and PC for
the definite management of critically ill patients with AC
irrespective of the presence or absence of gallbladder
stones and the use of antibiotics or supportive care.
Thus, studies with PC prior to CC will not be included.
Since no randomized controlled trials (RCTs) exist on
this topic, data for this systematic review will be ac-
quired mainly from retrospective studies; if the question
cannot be answered with certainty, this will inform the
decision on whether a randomized controlled trial is
needed and the number of patients required. Only stud-
ies published in English language will be included.
Relevant studies in languages other than English will
be considered, if an English translation is available. In
such cases, a translation will be requested from the
corresponding authors. Only articles published after the
comprehensive availability of modern surgical tech-
niques (minimal invasive surgery) as well as advances
in anesthesiology and intensive care medicine will be
included for analysis. Therefore, the search will be lim-
ited to articles published after January 1, 2000. Further-
more, all series with less than 20 participants as well as
case reports will be excluded. Since a high degree of
heterogeneity is expected, there will be no limits in the
length of follow-up.
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All patients included in eligible studies will be consid-
ered for analysis without restriction.
Interventions
Cholecystectomy and PC constitute the interventions to
be compared.
 Cholecystectomy will be defined as the surgical
removal of the gallbladder independent of the means
of access, i.e., laparoscopic or open.
 Percutaneous cholecystostomy refers to the
placement of a drain or a tube with the aim of
draining the gallbladder content. This is usually
performed under local anesthesia and image
guidance via ultrasound or computed tomography.
Primary outcomes
The primary outcomes will include in-hospital mortality,
30-day mortality, and the rate of complications. Only
procedure-related complications will be analyzed since
medical complications are not always procedure related.
Secondary outcomes
– Re-intervention: any form of surgical, endoscopic or
radiologic intervention following PC or CC
– Length of intensive care unit (ICU) stay
– Length of hospital stay
– Re-admission for biliary complaints
– Cost of treatment
Search for eligible studies
Systematic searches will be conducted across relevant
health databases including the Cochrane Library, Cumu-
lative Index of Nursing and Allied Health Literature
(CINAHL), MEDLINE, Embase, and Scopus using the
following keywords: (acute cholecystitis OR severe chole-
cystitis OR cholecystitis) AND (cholecystectomy OR
laparoscopic cholecystectomy OR open cholecystec-
tomy) AND (Cholecystostomy OR percutaneous chole-
cystectomy OR gallbladder drain OR gallbladder tube
OR transhepatic gallbladder drain OR transhepatic gall-
bladder tube OR cholecystostomy tube). The reference
lists of eligible articles will be hand searched. Articles
published after January 1 2000 will be identified using the
key terms “acute cholecystitis, cholecystectomy, and per-
cutaneous cholecystostomy.”
Study selection
The title and abstract of each article will be screened
and assessed against predetermined inclusion criteria by
two independent investigators MP and SW. Each investi-
gator must give a reason for rejecting any article. Unclearcases will be discussed with PA. A detailed full-paper as-
sessment will be performed for each study deemed eligible
for inclusion. This will be done independently and un-
blinded by MP, SW, and PA. Disagreements will be dis-
cussed with PA and if necessary, a fourth investigator, HZ,
will be consulted. All consensuses reached must be in ac-
cordance with the protocol. The corresponding authors of
eligible articles will be contacted for clarification (e.g.,
missing data, etc.) where necessary.
Data extraction
A data extraction sheet designed for this systematic re-
view by SK and PA will be used for data extraction. MP
and SW will independently extract data from the in-
cluded studies. PA will cross-check the extracted data.
Disagreements will be resolved in all cases via discus-
sion. If no agreement is reached, HZ will be consulted
for consensus.
The following information will be extracted:
– Publication language, year, and country of origin
– Baseline features: age, sex, American Society of
Anesthesiologists (ASA) score, and body mass
index (BMI)
– Size of study population
– Study design
– Inclusion criteria
– Type of intervention: PC and CC
– Allocation criteria for the respective interventions
– Length of ICU stay in days
– Length of hospital stay in days
– Duration of follow-up
– Morbidity and mortality rates
– Re-intervention: type and reasons of re-intervention
– Re-admission for biliary complaints
– Cost of treatment
Assessment of risk of bias
SK and MP will assess risk of bias of all the studies in-
cluded. As per the instructions outlined in the Cochrane
Handbook for systematic reviews of interventions, the
Newcastle-Ottawa scale will be used to assess quality of
non-randomized studies. Two previous systematic re-
views [16, 17] (search to 2012) identified no randomized
controlled trials directly comparing PC and CC; if an ad-
equate number of trials are identified in our search, the
analysis protocol proposed by the Cochrane Systematic
Review [17] will be followed. If necessary, the corre-
sponding authors of included articles will be contacted
for further information.
Measurement of treatment effect
Central tendencies will be reported in terms of means
and standard deviations where necessary. If not reported,
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ard error of the mean. The corresponding authors will
be contacted whenever such data are missing. Risk ratios
will be calculated where possible. All calculations will be
performed with a 95 % confidence interval. Furthermore,
the Fisher’s exact test will be used for the calculation of
significance, which will be set at p < 0.05. Adjusted effect
estimates will be analyzed in preference to the unadjusted
estimates, using inverse-variance weighted average. Pooled
estimates will only be presented after consideration of
both clinical and methodological heterogeneity of included
studies. If there is significant clinical or methodological
heterogeneity, we will consider pooling only homogeneous
studies. If this is thought to introduce too much bias, we
will abandon the meta-analysis altogether.
Unit of analysis
The unit of study will be critically ill patients with AC,
both calculous and acalculous cholecystitis.
Dealing with missing data
The responsible author will be contacted whenever pos-
sible to request for missing data. Assumption methods
used to cope with missing data will be clearly outlined.
If necessary, sensitivity analyses will be carried out to as-
sess how sensitive the results will react to changes in as-
sumption. These will be fully discussed in the review.
Assessment of heterogeneity
The Chi square test with a p value of 0.05 will be used to
explore heterogeneity while the quantity of heterogeneity
will be assessed using I2 statistics. I2 will be interpreted ac-
cording to the guidance for Cochrane reviews. It is ex-
pected that a random effects model will be used to build
up the meta-analysis.
Assessment of reporting bias
We plan to use visual inspection of the funnel plots to
assess reporting bias if sufficient studies are available.
We plan to use the linear regression approach described
by Egger [20] to determine the funnel plot asymmetry. Pos-
sible sources of any funnel plot asymmetry will be explored
since there may be publication bias but no asymmetry.
Subgroup analysis
Subgroup analyses will be performed for the primary
endpoints. These analyses will be stratified by groups of
patients managed with CC vs. PC. We will also perform
subgroup analyses stratified by gender, ASA score, age,
and BMI if possible. In the event that stratified gender,
ASA score, age, and BMI analyses are not possible, we
will use meta-regression to perform analyses adjusted
for the percentages of males/females, ASA scores, BMI
(mean or median), and age (mean or median).Sensitivity analysis
Sensitivity analysis will be performed to investigate the
influence of changes in the methods or data used in the
individual articles on the review. This will be done for
suitable features during the review process.Discussion
AC is a common diagnosis, and the management of crit-
ically ill patients can be challenging with high rates of
morbidity and mortality. While surgery is generally of-
fered to “fit for surgery” patients, the management of
critically ill patients is unclear. Percutaneous cholecys-
tostomy has been used in such patients after failure of
medical treatment. However, this procedure has been
shown to be associated with unacceptably high rates of
complications and mortality.
This systematic review will give an overview of the
existing data on the management of critically ill patients
with AC. Directly comparing the outcomes of patients
managed with cholecystectomy to those of similar pa-
tients managed with cholecystostomy may help facilitate
the clinical decision-making.
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